KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Invested Capital (2020 - 2025)

Historic Invested Capital for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $9.7 billion.

  • Organon's Invested Capital rose 532.35% to $9.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 billion, marking a year-over-year increase of 532.35%. This contributed to the annual value of $9.4 billion for FY2024, which is 761.8% up from last year.
  • According to the latest figures from Q3 2025, Organon's Invested Capital is $9.7 billion, which was up 532.35% from $9.6 billion recorded in Q2 2025.
  • Over the past 5 years, Organon's Invested Capital peaked at $9.7 billion during Q3 2025, and registered a low of $6.2 billion during Q1 2021.
  • Over the past 5 years, Organon's median Invested Capital value was $8.1 billion (recorded in 2023), while the average stood at $8.3 billion.
  • Within the past 5 years, the most significant YoY rise in Organon's Invested Capital was 2576.1% (2022), while the steepest drop was 63.79% (2022).
  • Quarter analysis of 5 years shows Organon's Invested Capital stood at $7.6 billion in 2021, then increased by 5.18% to $8.0 billion in 2022, then rose by 8.34% to $8.7 billion in 2023, then increased by 7.62% to $9.4 billion in 2024, then grew by 4.08% to $9.7 billion in 2025.
  • Its Invested Capital stands at $9.7 billion for Q3 2025, versus $9.6 billion for Q2 2025 and $9.5 billion for Q1 2025.